|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
If peripheral T cell lymphoma or T cell lymphomas of follicular helper origin are considered in the differential diagnosis, the following panel is recommended: pan T cell antigens, CD4, CD8, one or more follicular dendritic cell markers, and assessment for Epstein-Barr virus (EBV) infection, preferably EBV encoded RNA (EBER) as assessed by in situ hybridization When the differential diagnosis includes nodular lymphocyte predominant Hodgkin lymphoma, recommended additional studies include OCT2, CD21 and/or CD23, PD1, and assessment for EBV infection.
|
30802809 |
2019 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
It has been shown that both CD21 and CD83 contribute to the resolution of inflammation occurred in MS. CD21 and CD83 have also been ascribed to Epstein Barr virus (EBV) infection (the prime suspect of MS causality) and the levels of vitamin D, respectively.
|
29759135 |
2018 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
Anti-CD21 antibody inhibited in vitro infection of EBV, suggesting that CD21 plays a role in EBV infection into WILL4 cells.
|
28110206 |
2017 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
YCCEL1 cells expressed cytokeratin, but not CD21 and CD19, suggesting CD21-independent EBV infection.
|
23175241 |
2013 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
LF prevented EBV infection of primary B cells mediated by its direct binding to the EBV receptor (CD21) on the B-cell surface.
|
22433582 |
2012 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
Our study of a viral cell line model provides evidence to suggest that CD21-dependent viral entry plays a crucial role in type 2 AECs, indicative of an IL-4 response EBV infection in IPF.
|
19193442 |
2009 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
CD21 membrane receptor was absent after EBV infection, being a differential morphological feature of the tumoral cells.
|
15965273 |
2005 |
|
Epstein-Barr Virus Infections
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation.
|
12629653 |
2003 |
|
Epstein-Barr Virus Infections
|
0.100 |
AlteredExpression
|
group |
LHGDN |
These results suggest the possible modulation of EBV infection via thiol-dependent redox control of CD21, and thiol-antioxidants may be good candidates for controlling EBV infection.
|
11813981 |
2001 |
|
Epstein-Barr Virus Infections
|
0.100 |
AlteredExpression
|
group |
BEFREE |
An NPC cell line susceptible to EBV infection in vitro was established by transfection with a plasmid expressing a well-known EBV receptor, CR2.
|
9645762 |
1998 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
Group I Burkitt's lymphoma cell lines conditionally expressing the CD21 receptor for EBV infection were superinfected with EBV.
|
7856099 |
1995 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
A molecule, which is biochemically and immunologically similar to B-cell CD21, has been identified on a subpopulation of immature thymocytes, suggesting a role for this molecule in the regulation of T-cell development and further suggesting that immature T cells might be susceptible to EBV infection.
|
7811999 |
1995 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
These findings indicate that the HCL-O cell line is derived from the leukaemic hairy cells and possibly, in vitro EBV infection took place easily in the original hairy cells through their CD21, resulting in subsequent immortalization.
|
7985490 |
1994 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
Two of these, the genes for CD21 and vimentin, were previously known to be induced by EBV infection.
|
8383238 |
1993 |
|
Epstein-Barr Virus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
Hairy cells are not readily susceptible to EBV infection in vitro, even though they are EBV receptor-positive B cells.
|
2823016 |
1987 |